Naamidine A reveals a promising zinc-binding strategy for topical antifungal therapy

Antimicrob Agents Chemother. 2024 Nov 6;68(11):e0119424. doi: 10.1128/aac.01194-24. Epub 2024 Sep 26.

Abstract

Fungal disease affects over a billion people worldwide. Naamidine A inhibits the growth of diverse fungal pathogens through an unknown mechanism. Here, we show that the supplementation of medium with excess zinc abolishes the antifungal activity of naamidine A. Furthermore, we highlight that naamidine A has in vitro activity against terbinafine-resistant Trichophyton spp. and in vivo efficacy in a mouse model of dermatomycosis caused by T. mentagrophytes, highlighting its therapeutic potential as a topical treatment.

Keywords: Candida albicans; Trichophyton; dermatomycosis; drug-resistant; metal chelation; natural product; zinc.

MeSH terms

  • Administration, Topical*
  • Animals
  • Antifungal Agents* / pharmacology
  • Antifungal Agents* / therapeutic use
  • Arthrodermataceae
  • Dermatomycoses / drug therapy
  • Disease Models, Animal
  • Drug Resistance, Fungal / drug effects
  • Humans
  • Mice
  • Microbial Sensitivity Tests*
  • Terbinafine / pharmacology
  • Terbinafine / therapeutic use
  • Tinea / drug therapy
  • Tinea / microbiology
  • Trichophyton / drug effects
  • Zinc*

Substances

  • Antifungal Agents
  • Zinc
  • Terbinafine

Supplementary concepts

  • Trichophyton mentagrophytes